Dysmenorrhea

Pelvic, Dysmenorrhea Pain Sustained Relief With Elagolix

Pelvic, Dysmenorrhea Pain Sustained Relief With Elagolix

By

Treatment with elagolix was associated with sustained reduction in average monthly dysmenorrhea and non-menstrual pelvic pain through a 12-month treatment period.

Elagolix May Be Effective for Reducing Pain From Endometriosis

Elagolix May Be Effective for Reducing Pain From Endometriosis

By

At 3 months, significantly more women receiving both doses of elagolix had reductions in dysmenorrhea and nonmenstrual pelvic pain compared with those receiving placebo.

Functional Neural Connectivity Underlying Pain Experienced in Migraine, Dysmenorrhea

Functional Neural Connectivity Underlying Pain Experienced in Migraine, Dysmenorrhea

Results from studies evaluating various pain modalities indicate alterations within and between resting state functional networks.

Sign Up for Free e-Newsletters